Outset Medical GC awarded 59,830 stock RSUs
Brottem John L. reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Brottem John L. reported acquisition or exercise transactions in this Form 4 filing.
Outset Medical, Inc. reported that its General Counsel, John L. Brottem, received a grant of 59,830 restricted stock units (RSUs) of common stock on June 26, 2026. Each RSU represents one share of common stock. Following this award, his direct holdings total 90,107 shares. The RSUs vest 33.33% on June 26, 2027, with the remaining 66.67% vesting in equal quarterly installments over the next two years, subject to his continuous service.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 59,830 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents restricted stock units ("RSU") granted to the reporting person on June 26, 2026. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on June 26, 2027, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date.
Key Figures
Key Terms
restricted stock units ("RSU") financial
vest financial
continuous service financial
AI-generated analysis. How Rhea-AI works. Not financial advice.